Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Reconciliation of Net Loss (Details)

v3.21.2
Net Loss Per Share - Reconciliation of Net Loss (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Net Loss Per Share        
Net loss $ (6,620,576) $ (4,536,818) $ (14,243,716) $ (10,910,238)
Net loss: Non-controlling interest (77,379) (82,388) (168,341) (163,702)
Net loss attributable to Heat Biologics, Inc. $ (6,543,197) $ (4,454,430) $ (14,075,375) $ (10,746,536)
Weighted Average Number of Shares Outstanding, Basic and Diluted 25,137,466 12,561,549 24,671,281 10,372,352
Net loss per share, basic and diluted $ (0.26) $ (0.35) $ (0.57) $ (1.04)